![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GENE LOGIC ENTERS INTO AGREEMENT WITH LILLY TO DISCOVER NEW DEVELOPMENT PATHS FOR MULTIPLE CLINICAL DRUG CANDIDATES
GENE LOGIC ENTERS INTO AGREEMENT WITH LILLY TO DISCOVER NEW DEVELOPMENT PATHS FOR MULTIPLE CLINICAL DRUG CANDIDATES
Gene Logic Inc. announced that it has entered into a drug repositioning and development agreement with Eli Lilly and Company to seek alternative development paths for multiple Lilly drug candidates. All of these drug candidates were discontinued or de-prioritized in clinical trials for reasons other than safety. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=6852115)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct